Vita Risk and Macula Risk AMD Genetic Testing

Vita Risk is a pharmacogenetic test designed to aid in the selection of appropriate eye supplement formulations for a patient diagnosed with intermediate Dry Age-related Macular Degeneration.

Macula Risk PGx is a combined pharmacogenetic and prognostic DNA test  to determine the patient’s risk of progression to advanced AMD based on their individual genetic risk profile and to aid in the selection of appropriate eye supplement formulations for a patient diagnosed with intermediate Dry Age-related Macular Degeneration. Vita Risk pharmacogenetic results may be ordered separately or included within the Macula Risk PGx test.